| Revenue Growth | Semi $135M (65% of rev); Compound Semi $40M; Data Storage $20M. |
|---|---|
| Mgmt Confidence | Highly optimistic about AI infrastructure; confident in exceeding $1B revenue 2027. |
| Demand Visibility | Strong backlog; visibility into 2027 and 2028 for advanced packaging. |
| Order Book | Customer deposits increased $58M to $169M, reflecting strong commitment. |
| Margin Trends | Q3 gross margin 39% (below expectations); Q4 guided 43%-44%. |
| Op. Leverage | Investing in supply chain and capacity to support future scaling. |
| Pricing Power | Differentiated IBD technology addresses critical high-power laser requirements. |
| Vol vs Price | Growth driven by volume and mix; ASPs for tools $5M-$10M. |
| Segment Growth | Advanced packaging and Silicon Photonics expected to lead 2027 growth. |
| New Clients | Engaged Tier 1 Foundry on next-gen wet processing panel tool. |
| Capex & Debt | Pending merger with Excelitas; $483M cash; $4M Q3 CAPEX. |
| Regulatory | Awaiting China regulatory review for Excelitas merger; expected close Q1 2027. |
| Commentary | Strategic focus on AI-driven technology transitions in logic, memory, and packaging. |
| New Launches | Lumina Plus MOCVD; IBD-300 for DRAM; NSA system for logic. |
Growth
Q3 revenue $209M; Semiconductor segment grew 4% sequentially; Compound Semi revenue doubled year-over-year.
Outlook
Targeting $1B+ revenue for 2027; doubling manufacturing capacity; 40% growth expected in 2027.
Risks
Supply chain component constraints and longer lead times; China revenue declined to 12%.
The company's earnings call, NASDAQ: VECO, and its 8-K filed with the SEC. Summary written with AI assistance from the call.
Earnings call webcast ↗ Watch on YouTube ↗
Veeco Instruments Inc: key numbers
- Share price
- $37.20Close, Nov 16
- Market cap
- $2.27B
- Shares outstanding
- 61.14MLatest SEC cover page
- Sector
- Technology
- Industry
- Special Industry Machinery, NECSIC 3559
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Veeco Instruments Inc
All →Veeco Instruments Director Mary Jane Raymond Sells $80K of Stock
Mary Jane Raymond, Director, sold 2,000 shares of Veeco Instruments Inc at $40.00 a share, worth $80K in total on Nov 9, 2026. Shares held after the trade: 23,967 (-7.7%).
- Value
- $80K
- Shares
- 2,000
- Price
- $40.00
- Role
- Director
- Holding change
- -7.7%
- Trade date
- Nov 9, 2026
Veeco Instruments Q3 2026 Results: Net Income $13.6M, Up 28.7% YoY
Veeco Instruments reported net sales of $209.4 million for the third quarter of 2026, a significant increase from $165.9 million in the prior year. Despite higher revenue, nine-month net income decreased to $25.2 million from $34.3 million year-over-year, primarily due to higher operating expenses and merger-related costs associated with the pending acquisition by Axcelis Technologies.
- Key figure
- Net income $13.6M · +28.7% YoY
Veeco Instruments Financial Results
Veeco Instruments reported Q3 2026 revenue of $209.4 million, a significant increase from $165.9 million in the prior year, driven by AI infrastructure investment and demand for semiconductor process equipment. The company provided Q4 revenue guidance of $230 million to $260 million and expressed confidence in reaching $1 billion in annual revenue by 2027.
- Term
- Q3 2026
“Veeco’s third-quarter performance reflects solid execution and significant opportunities across our business. AI infrastructure investment is accelerating technology transitions across leading-edge logic and memory, advanced packaging, and high-speed optical connectivity. This is driving unprecedented customer engagement and order activity across our differentiated portfolio. With greater visibility and strategic investments to expand our manufacturing capacity, we believe Veeco is well positioned to exceed one billion dollars in revenue for the full year 2027.”
Bill Miller, Ph.D., Veeco’s Chief Executive Officer
Veeco Instruments M&A Deal with Axcelis Technologies, Inc.
Veeco Instruments and Axcelis Technologies provided a status update on their pending all-stock merger, now expecting the deal to close by the end of Q1 2027. The delay is attributed to pending regulatory approval from China's SAMR and the need to refile for HSR Act clearance due to the expiration of the previous waiting period.
- Counterparty
- Axcelis Technologies, Inc.